Ole Henrik Bang-Andreasen

AVANT BIO thesis

Our Approach A laser focus on the enabling technologies shaping how tomorrow’s therapeutics are developed. We Are Focused We See New Opportunities We Catalyze Value We Are Focused AVANT BIO is dedicated to fueling innovative companies in the Life Sciences and Healthtech space that are developing Therapeutic-Enabling Technologies capable of making therapies more accessible and unlocking new possibilities. Thematic Focus Equitable Access to Therapies Globally Speed and Quality in Drug Discovery New Modalities, New Needs Robust, Reliable manufacturing & Supply Chain Clinical Trial Access, Diversi

Sector and stage focus

• Series A: BioTech, Pharmaceuticals, Therapeutics, Medical Devices, Diagnostics, Digital Health, Health IT
• Seed: Pharmaceuticals, BioTech, Health IT, Diagnostics, Digital Health, Therapeutics, Medical Devices
• Series B: Pharmaceuticals, BioTech, Medical Devices, Health IT, Diagnostics, Digital Health, Therapeutics

Is Ole Henrik Bang-Andreasen a fit for your round?

Upload your pitch deck and see whether Ole Henrik Bang-Andreasen appears in your top 20 matches.